A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The City of Rochester’s news conference will be live-streamed in this page starting at 11:30 a.m. ROCHESTER, N.Y. (WROC) — City leaders are providing a public safety ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...

The letter will indicate our intent to conduct a simultaneous ... that the sponsor submits to both regulators should be identical in every way (for example, drug formulation, proposed dosage, proposed ...

Dan is a senior editor at Raw Story based in Colorado, producing and editing breaking political news. Dan previously worked as a news associate at The Associated Press in Philadelphia, and later ...

For example, drugs such as Victoza, a diabetes medication, once available to clinics at nearly no cost, now come with higher prices. The shift in pricing has caused a ripple effect, limiting ...

Body Dimensions 163.3 x 76.6 x 8.2 mm (6.43 x 3.02 x 0.32 in) ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...